Search research articles
Contact Us
Filters
Showing results (91-100 of 126) with videos related to
Page
of 13
Sort By:
Stem Cell Reports
|
May 31, 2016
Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice
Peng Zhang, Caihong Xing, Steven D Rhodes, et al.
Genomics, Proteomics & Bioinformatics
|
June 17, 2018
Tet2 Regulates Osteoclast Differentiation by Interacting with Runx1 and Maintaining Genomic 5-Hydroxymethylcytosine (5hmC)
Yajing Chu, Zhigang Zhao, David Wayne Sant, et al.
Cell Reports
|
November 21, 2015
Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice
Zhigang Zhao, Li Chen, Meelad M Dawlaty, et al.
The Journal of Cell Biology
|
June 19, 2013
The tumor suppressor CDKN3 controls mitosis
Grzegorz Nalepa, Jill Barnholtz-Sloan, Rikki Enzor, et al.
Blood
|
April 7, 2017
Caspase-3 controls AML1-ETO-driven leukemogenesis via autophagy modulation in a ULK1-dependent manner
Na Man, Yurong Tan, Xiao-Jian Sun, et al.
The Journal of Clinical Investigation
|
December 11, 2012
Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk
Karl Staser, Su-Jung Park, Steven D Rhodes, et al.
Nature Communications
|
December 31, 2024
DDX18 coordinates nucleolus phase separation and nuclear organization to control the pluripotency of human embryonic stem cells
Xianle Shi, Yanjing Li, Hongwei Zhou, et al.
Cell
|
November 6, 2008
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow
Feng-Chun Yang, David A Ingram, Shi Chen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 25, 2013
Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model
Steven D Rhodes, Xiaohua Wu, Yongzheng He, et al.
The Journal of Clinical Investigation
|
November 2, 2023
Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical models
Guo Ge, Peng Zhang, Pinpin Sui, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 126) with videos related to
Sort By:
Page
of 13
Stem Cell Reports
|
May 31, 2016
Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice
Peng Zhang, Caihong Xing, Steven D Rhodes, et al.
Genomics, Proteomics & Bioinformatics
|
June 17, 2018
Tet2 Regulates Osteoclast Differentiation by Interacting with Runx1 and Maintaining Genomic 5-Hydroxymethylcytosine (5hmC)
Yajing Chu, Zhigang Zhao, David Wayne Sant, et al.
Cell Reports
|
November 21, 2015
Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice
Zhigang Zhao, Li Chen, Meelad M Dawlaty, et al.
The Journal of Cell Biology
|
June 19, 2013
The tumor suppressor CDKN3 controls mitosis
Grzegorz Nalepa, Jill Barnholtz-Sloan, Rikki Enzor, et al.
Blood
|
April 7, 2017
Caspase-3 controls AML1-ETO-driven leukemogenesis via autophagy modulation in a ULK1-dependent manner
Na Man, Yurong Tan, Xiao-Jian Sun, et al.
The Journal of Clinical Investigation
|
December 11, 2012
Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk
Karl Staser, Su-Jung Park, Steven D Rhodes, et al.
Nature Communications
|
December 31, 2024
DDX18 coordinates nucleolus phase separation and nuclear organization to control the pluripotency of human embryonic stem cells
Xianle Shi, Yanjing Li, Hongwei Zhou, et al.
Cell
|
November 6, 2008
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow
Feng-Chun Yang, David A Ingram, Shi Chen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 25, 2013
Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model
Steven D Rhodes, Xiaohua Wu, Yongzheng He, et al.
The Journal of Clinical Investigation
|
November 2, 2023
Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical models
Guo Ge, Peng Zhang, Pinpin Sui, et al.
Page
of 13